Semaglutide

Description

Semaglutide, an injectable drug already approved by the Food and Drug Administration as a treatment for Type 2 diabetes, produced moderate weight loss at its dose of 1 milligram weekly.

Semaglutide is a once a week injection that increases insulin production and lowers blood suregal levels. It can also reduce appetite, lowering food intake and increasing weight loss. It has also been known to decrease cardiovascular outcomes in people with Type 2 Diabetes. 

Potential Benefits

• Decrease Appetite
• Lose Weight & Body Fat
• Slows Digestion

How Semaglutide works.

Semaglutide is a Glucagon-like peptide-1 (GLP-1) produced by the gut. It increases insulin production, a hormone that lowers the blood sugar level while inhibiting glucagon secretion, which is a hormone that raises blood sugar, reduces appetite and energy intake while delaying gastric emptying.

• Reduces food intake by lowering appetite.
• Slows food digestion in the stomach.
• Decreases body fat percentage.
• Weight loss.
• Decreased cardiovascular outcomes in subjects with Type 2 diabetes and cardiovascular disease.
• Lower HbA1c levels

Enhance the growth of ß cells in the pancreas.

Who should not take semaglutide?

You should not use semaglutide if you are allergic to it, or if you have: multiple endocrine neoplasia type 2 (tumors in your glands); a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer); or. diabetic ketoacidosis (call your doctor for treatment).